Towards practical application of deep learning in diagnosis of Alzheimer's disease [0.03%]
深度学习在阿尔茨海默病诊断中的应用研究
Harshit Parmar,Eric Walden;Alzheimer&#x;s Disease Neuroimaging Initiative *
Harshit Parmar
Background: Accurate diagnosis of Alzheimer's disease (AD) is both challenging and time consuming. With a systematic approach to diagnosis, steps can be taken toward improved treatment and prevention of the disease. ...
TREM2 in Alzheimer's disease: A global bibliometric analysis of research evolution and therapeutic implications [0.03%]
TREM2在阿尔茨海默病研究中的演变和治疗意义的全球文献计量分析
Linjing Cui,Zhang Yue,Chen Sun et al.
Linjing Cui et al.
Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor genetically linked to Alzheimer's disease (AD) and increasingly recognized as a key regulator of neuroinflammation, yet its glo...
Characteristics of publicly available digital dementia risk screening tools: A scoping review [0.03%]
公开可用的数字痴呆症筛查工具的特点：一项综述研究
Zandile Rwodzi,Maddison L Mellow,Dan Ping Wu et al.
Zandile Rwodzi et al.
Background: Alzheimer's disease and related dementias have long prodromal phases during which addressing modifiable lifestyle factors may help delay onset. Digital dementia risk screening tools are emerging as an accessib...
Diagnostic association of ante-mortem biomarkers with cerebral amyloid angiopathy in a cohort with high Alzheimer's disease comorbidity [0.03%]
在阿尔茨海默病共病率高的队列中，脑淀粉样血管病的术前生物标志物诊断关联性研究
Kemi Hou,Haojun Lu,Rong Zhang et al.
Kemi Hou et al.
Background: Cerebral amyloid angiopathy (CAA) frequently co-occurs with Alzheimer's disease (AD), complicating the interpretation of biomarkers. Current diagnostic approaches rely largely on neuroimaging but remain constr...
Exploring shared molecular pathways and gene signatures in type 2 diabetes mellitus and Alzheimer's disease in a Pakistani cohort [0.03%]
在巴基斯坦人群中探索2型糖尿病和阿尔茨海默病的共同分子通路和基因特征
Zarish Noreen,Tanmoy Mondal,Jheannelle Johnson et al.
Zarish Noreen et al.
Background: Type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) a growing concern in low- and middle-income countries, including Pakistan. The relationship between T2DM and AD is complex and concerning, as more o...
Comprehensive and stratified meta-analysis of diffusion tensor image analysis along the perivascular space in Alzheimer's disease: Linking glymphatic dysfunction with cognitive decline and amyloid pathology [0.03%]
全面分层的沿血管周围空间的老年痴呆患者扩散张量成像元分析：将glymphatic功能障碍与认知衰退和淀粉样蛋白病理相联系
Rasa Zafari,Tina Taherkhani,Amirhossein Kamroo et al.
Rasa Zafari et al.
Background: The glymphatic system clears brain waste, including amyloid-β (Aβ), and it is shown that its dysfunction may contribute to Alzheimer's disease (AD) pathology. This dysfunction can be evaluated using the diff...
N-Glycosylation and Alzheimer's disease: A 2001-2025 global bibliometric landscape revealing emerging diagnostic trends [0.03%]
N-糖基化与阿尔茨海默病：揭示新兴诊断趋势的2001-2025年全球文献计量学格局
GuoXun Shi,Feng Ju,QiGang Dong et al.
GuoXun Shi et al.
Background: Alzheimer's disease (AD) lacks effective early diagnostic tools. N-glycosylation dysregulation involving the enzyme MGAT3 is implicated in AD pathogenesis, with untapped clinical potential for biomarker develo...
Multidimensional burden of caregivers of Alzheimer's disease and related dementia in China: A nationwide cross-sectional study [0.03%]
中国阿尔茨海默病及相关痴呆照料者的多维负担：一项全国性横断面研究
Dangui Zhang,Yongleng Fang,Minglong Huang et al.
Dangui Zhang et al.
Background: As China's population ages, the burden on caregivers of individuals with Alzheimer's disease and related dementias (ADRD) is increasing. Comprehensive nationwide studies on caregiver burden, particularly emoti...
Corrigendum to Unraveling the impact of common medications on biomarker patterns in Alzheimer's disease and mild cognitive impairment [0.03%]
关于阿尔茨海默病和轻度认知障碍中常见药物对生物标志物模式影响的再调查的勘误表
[This corrects the article DOI: 10.1177/25424823251387281.]. © The Author(s) 2026.
The Cheung Glutamatergic Regimen as a candidate for primary and secondary prevention of Alzheimer's disease onset [0.03%]
张氏谷氨酸治疗方案作为预防阿尔茨海默病发病的一线和二线疗法候选方案
Ngo Cheung
Ngo Cheung
Ketamine's ability to lift mood and spur new synapse growth has put glutamate biology at the center of modern neurotherapeutics. Yet the drug's intravenous route, monitoring requirements, and dissociative effects make it a poor candidate fo...